Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (296)	2/19/2003 10:54:47 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ABGX Going up for a third day on a roll after making a 52wks L last Thursday at 4.52<g> The up-move continues today in spite of the announcement that it halted a trial of its ABX-CBL, that was co-developing with SANG,because it showed no advantage over PHA's Atgam in treating GVHD. The stock had been trading around 0.7 of book and institutions that hold close to 110% of the float had reportedly been doing some buying in spite of slight insiders selling.<g> The earnings report and C.C, is scheduled for tomorrow.Today's volume remains relatively low. The analysts' consensus one yr. target for ABGX is around $13(That is above its Nov. H <g>) siliconinvestor.com siliconinvestor.com Bernard